Koers Lexagene Holdings Inc Toronto S.E.
Aandelen
WEY
CA52886L1031
Biotechnologie & Medisch Onderzoek
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jack Regan
CEO | Chief Executive Officer | - | 26-04-07 |
Jeffrey Mitchell
DFI | Director of Finance/CFO | - | 01-03-18 |
Steven Armstrong
COO | Chief Operating Officer | - | 24-03-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Joseph P. Caruso
BRD | Director/Board Member | 65 | 18-06-18 |
Jack Regan
CEO | Chief Executive Officer | - | 26-04-07 |
Tom Slezak
BRD | Director/Board Member | - | 12-10-16 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-32,63% | 9,2 mld. | |
+23,12% | 2,8 mld. | |
-18,33% | 2,05 mld. | |
-24,39% | 1,59 mld. | |
+65,65% | 1,44 mld. | |
+32,83% | 830 mln. | |
-6,77% | 720 mln. | |
-29,80% | 507 mln. | |
+0,40% | 297 mln. |